Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Haemato AG Earnings Release 2016

Aug 29, 2016

5404_rns_2016-08-29_6aec25d0-785c-4aa1-9d9f-8f6e2a06c93c.html

Earnings Release

Open in viewer

Opens in your device viewer

News Details

Corporate | 29 August 2016 09:52

HAEMATO AG – H1 2016: Sales growth 40% to EUR 142.27 million, EBIT-growth 40% to EUR 5.93 million, compared to prior year period

DGAP-News: HAEMATO AG / Key word(s): Half Year Results/Dividend

2016-08-29 / 09:52

The issuer is solely responsible for the content of this announcement.


Corporate News der HAEMATO AG:

H1 2016: Sales growth 40% to EUR 142.27 million, EBIT-growth 40% to EUR 5.93 million, compared to prior year period

In the second quarter 2016 HAEMATO AG, Berlin (ISIN: DE0006190705), achieved IFRS Group sales of EUR 74.33 million (prior year period: EUR 56.16 million), a growth of 31.9% was achieved. The pleasant sales achievement in the first quarter of EUR 67.94 million was run up by 9.4%.

In the first half-year HAEMATO achieved IFRS Group sales of EUR 142.27 million (prior year period: EUR 101.48 million), a growth of 40% was produced.

The operating result (EBIT) increased as well by 40% to EUR 5.93 million (prior year period: EUR 4.21 million). The annual general meeting was held in June 2016. The shareholders decided again on a dividend pay of 30 Cent per share.

“HAEMATO expanded sales from first quarter to second quarter. For the following quarters we expect as well a good business development”, says Dr. Christian Pahl, Member of the Management Board of HAEMATO AG.

About HAEMATO:

HAEMATO AG, founded in 1993, is a pharmaceutical company. The focus of the business activities lies on the growth markets of patent free and patent protected medicinal products. Focal points are therapies with cancer, HIV and other chronic diseases.

HAEMATO AG is listed in the Entry Standard (Open Market) on the

Frankfurt Stock Exchange. Key figures for the share of HAEMATO AG:

Subscribed capital: EUR 20,778,898

Listed shares: ordinary shares

ISIN: DE000619070

WKN: 619070

Stock symbol: HAE

Contact:

HAEMATO AG, Investor Relations

Telefon: +49 (0)30 897 30 86 70

[email protected]


2016-08-29 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de


show this